House Bill 1127, titled the Affordable Maternal Access & Cancer Care Act, would create two new grant-and-screening programs within the Department of Health and Human Services and expand insurance protections for breast cancer-related imaging. The bill establishes a Maternal Care Access Grant Program to fund community-based organizations that work to reduce maternal mortality and severe maternal morbidity, especially among marginalized and underserved populations. It directs the Department to award competitive grants, provide outreach and technical assistance, and prioritize applicants led by people from communities that have historically faced barriers to health and human services. The bill also appropriates recurring state funds to support the program and a dedicated program coordinator position.
The bill separately creates a statewide Prostate Cancer Control Program to provide free or low-cost prostate cancer screenings and follow-up care for uninsured or underinsured men who do not have Medicare Part B or Medicaid and who meet age, family history, and income criteria. In addition, it revises North Carolina insurance law to require coverage parity for diagnostic and supplemental breast imaging, such as breast MRI and ultrasound, so that these services cannot have less favorable cost-sharing than screening mammography. It also applies these coverage requirements to the State Health Plan and appropriates funds to help the plan comply.
HB1127 would amend and recodify several statutes in Chapters 58, 90, and 135 of the General Statutes. It would create new coverage rules for breast cancer screening, diagnostic, and supplemental imaging; repeal older provisions and replace them with a broader parity framework; and add billing restrictions so out-of-network providers cannot bill patients above the insurer reimbursement amount for certain breast cancer prevention services. The bill also requires reporting to legislative oversight committees on grant spending, outreach effectiveness, and program outcomes.
The overall sentiment reflected in the bill text is strongly supportive of expanded access to maternal health services, cancer screening, and reduced out-of-pocket costs for medically necessary imaging. The findings section emphasizes disparities in maternal outcomes, delayed prostate cancer detection among uninsured and underinsured men, and financial barriers to breast imaging, suggesting a public-health-oriented rationale. No committee transcript or vote record is available in the provided materials, so there is no recorded debate or formal vote sentiment to assess.
The main points of potential contention are likely to be fiscal and regulatory. The bill includes recurring appropriations totaling millions of dollars, creates a new state position, and imposes new insurance coverage and billing mandates that would affect insurers, the State Health Plan, and healthcare providers. It also uses targeted eligibility criteria for grants and prostate screening, which could prompt questions about administrative complexity, provider reimbursement, and whether the state should directly fund these services versus relying on existing programs.
HB1127 would significantly expand state involvement in maternal health and cancer prevention by creating new DHHS-administered grant and screening programs and by mandating insurance coverage parity for supplemental and diagnostic breast imaging. It would amend North Carolina insurance statutes to require coverage for breast MRI, breast ultrasound, and related diagnostic services on terms no less favorable than screening mammography, apply those requirements to the State Health Plan, and impose billing limits on noncontracted providers for certain breast cancer prevention services. The bill would also appropriate recurring General Fund dollars for program operations, a dedicated coordinator position, and State Health Plan compliance, while adding reporting obligations and recodifying/repealing several existing statutory provisions.
The bill’s tone and structure indicate strong support for maternal health equity, early cancer detection, and reduced patient cost barriers. Its findings frame the legislation as a response to preventable disparities and access problems, and the bill is designed to direct resources toward underserved communities and uninsured or underinsured patients. Because no committee discussion or vote history was provided, there is no evidence of recorded opposition or amendment debate in the available materials.
Likely areas of contention are the bill’s recurring appropriations, the creation of a new permanent DHHS position, and the scope of new insurance and billing mandates. Insurers and employers may object to the added coverage requirements and State Health Plan costs, while healthcare providers may be concerned about reimbursement limits and billing restrictions for out-of-network services. Some lawmakers may also question the targeted eligibility criteria for grants and prostate screening, the administrative burden of outreach and reporting, and whether the state should fund these services directly rather than through existing health programs.